Table 3.

Univariate and multivariate analyses of disease-free survival for breast cancer

VariablesItemUnivariateMultivariate
Hazard rate ratio95% CIPHazard rate ratio95% CIP
StageIII/IV5.332.25–12.62<0.0016.081.83–20.180.003
I/II1.001.00
GradeIII1.380.55–3.420.4911.100.39–3.050.862
I/II1.001.00
Age, y504.271.56–11.660.0052.190.73–6.560.163
≤501.001.00
BMI, kg/m2<241.790.76–4.220.1831.540.59–4.040.377
≥241.001.00
ERNegative2.451.04–5.770.0410.690.12–3.940.674
Positive1.001.00
PRNegative1.990.84–4.720.1203.760.74–19.150.111
Positive1.001.00
Her2/neuPositive0.700.27–1.800.4550.640.22–1.870.413
Negative1.001.00
RadiotherapyYes0.690.29–1.620.3931.030.37–2.920.951
No1.001.00
ChemotherapyYes1.450.43–4.910.5550.880.23–3.410.848
No1.001.00
Hormone therapyYes0.180.07–0.47<0.0010.440.11–1.760.247
No1.001.00
VisfatinHigh5.731.92–17.140.0024.111.15–14.700.030
Low1.001.00